Alan Lotvin is EVP&President-PharmacyServices of CVS HEALTH Corp. Currently has a direct ownership of 109,183 shares of CVS, which is worth approximately $6.33 Million. The most recent transaction as insider was on Aug 04, 2022, when has been sold 22,541 shares (Common Stock) at a price of $104.0 per share, resulting in proceeds of $2,344,264. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
0% 3M change
0% 12M change
Total Value Held $6.33 Million

Alan Lotvin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 04 2022
SELL
Open market or private sale
$2,344,264 $104.0 p/Share
22,541 Reduced 17.11%
109,183 Common Stock
Aug 04 2022
BUY
Exercise of conversion of derivative security
$1,402,276 $62.21 p/Share
22,541 Added 14.61%
131,724 Common Stock
Aug 03 2022
SELL
Open market or private sale
$11,848,102 $98.0 p/Share
120,899 Reduced 52.55%
109,183 Common Stock
Aug 03 2022
BUY
Exercise of conversion of derivative security
$6,801,778 $56.26 p/Share
120,899 Added 43.09%
159,684 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$3,854,460 $101.09 p/Share
38,129 Reduced 25.88%
109,183 Common Stock
Feb 21 2022
BUY
Grant, award, or other acquisition
-
85,971 Added 36.85%
147,312 Common Stock
Feb 01 2022
SELL
Open market or private sale
$2,277,609 $106.5 p/Share
21,386 Reduced 25.85%
61,341 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
$2,186,932 $102.26 p/Share
21,386 Added 20.54%
82,727 Common Stock
Dec 27 2021
SELL
Payment of exercise price or tax liability
$17,756 $88.78 p/Share
200 Reduced 3.32%
5,827 Common Stock (restricted)
Jun 28 2021
SELL
Open market or private sale
$232,686 $83.67 p/Share
2,781 Reduced 4.36%
61,047 Common Stock
Apr 03 2021
SELL
Payment of exercise price or tax liability
$126,682 $74.3 p/Share
1,705 Reduced 2.6%
63,828 Common Stock
Apr 01 2021
SELL
Payment of exercise price or tax liability
-
42,431 Reduced 40.75%
61,690 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
95,669 Added 47.88%
104,121 Common Stock
Jan 08 2021
SELL
Open market or private sale
$1,937,700 $75.0 p/Share
25,836 Reduced 75.54%
8,368 Common Stock
Jan 08 2021
BUY
Exercise of conversion of derivative security
$1,659,705 $64.24 p/Share
25,836 Added 43.03%
34,204 Common Stock
Nov 13 2020
SELL
Open market or private sale
$499,660 $70.0 p/Share
7,138 Reduced 47.08%
8,023 Common Stock
May 11 2020
BUY
Open market or private purchase
$315,650 $63.13 p/Share
5,000 Added 24.8%
15,161 Common Stock
Apr 01 2020
SELL
Payment of exercise price or tax liability
$86,402 $58.34 p/Share
1,481 Reduced 12.72%
10,161 Common Stock
Feb 28 2020
SELL
Payment of exercise price or tax liability
$9,469 $59.18 p/Share
160 Reduced 1.89%
8,303 Common Stock
Feb 28 2020
BUY
Grant, award, or other acquisition
$699,981 $59.18 p/Share
11,828 Added 29.74%
27,945 Stock Unit
Apr 01 2019
SELL
Payment of exercise price or tax liability
$46,766 $54.19 p/Share
863 Reduced 10.22%
7,578 Common Stock
Feb 28 2019
SELL
Payment of exercise price or tax liability
$16,886 $57.83 p/Share
292 Reduced 5.03%
5,508 Common Stock
Feb 28 2019
BUY
Grant, award, or other acquisition
$366,758 $57.83 p/Share
6,342 Added 29.52%
15,141 Stock Unit

Also insider at

DNAC
Social Capital Suvretta Holdings Corp. III
AL

Alan Lotvin

EVP&President-PharmacyServices
Woonsocket, RI

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS